How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence? The case of ethylene dibromide

Irva Hertz-Picciotto, N. Gravitz, R. Neutra

Research output: Contribution to journalArticle

18 Scopus citations


Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.

Original languageEnglish (US)
Pages (from-to)205-214
Number of pages10
JournalRisk Analysis
Issue number2
StatePublished - 1988
Externally publishedYes


ASJC Scopus subject areas

  • Safety, Risk, Reliability and Quality
  • Social Sciences (miscellaneous)

Cite this